TuisONC • TSE
add
Oncolytics Biotech Inc
Vorige sluiting
$0,45
Dagwisseling
$0,45 - $0,50
Jaarwisseling
$0,45 - $2,08
Markkapitalisasie
43,52 m CAD
Gemiddelde volume
125,25 k
P/V-verhouding
-
Dividend-opbrengs
-
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (CAD) | Mrt. 2025info | J/J-verandering |
|---|---|---|
Inkomste | — | — |
Bedryfskoste | 7,00 m | -19,79% |
Netto inkomste | -6,69 m | 3,00% |
Netto winsgrens | — | — |
Wins per aandeel | -0,08 | 11,11% |
EBITDA | -6,97 m | 19,83% |
Effektiewe belastingkoers | — | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (CAD) | Mrt. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 15,30 m | -48,31% |
Totale bates | 19,70 m | -43,30% |
Totale aanspreeklikheid | 13,21 m | 12,11% |
Totale ekwiteit | 6,49 m | — |
Uitstaande aandele | 88,82 m | — |
Prys om te bespreek | 5,62 | — |
Opbrengs op bates | -87,73% | — |
Opbrengs op kapitaal | -240,66% | — |
Kontantvloei
Netto kontantverandering
| (CAD) | Mrt. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | -6,69 m | 3,00% |
Kontant van bedrywe | -6,50 m | 13,00% |
Kontant van beleggings | — | — |
Kontant van finansiering | 5,89 m | 293,98% |
Netto kontantverandering | -639,00 k | 87,96% |
Beskikbare kontantvloei | -4,25 m | 22,67% |
Meer oor
Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that: induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
Gestig
1998
Hoofkwartier
Webwerf
Werknemers
28
